McDonald's Embraces Protein Trend Amid Rising Use of Weight-Loss Medications
McDonald's has become the latest fast-food giant to strategically adapt to the growing number of Americans using GLP-1 weight-loss drugs, such as Ozempic and Wegovy, by teasing new protein-rich menu items. This move reflects a broader industry shift as chains respond to changing consumer appetites and dietary preferences driven by these medications.
CEO Highlights Changing Consumer Behaviour
During an earnings call last Wednesday, CEO Chris Kempczinski noted that McDonald's is actively testing menu options to appeal to customers on GLP-1 drugs, who often prefer meals higher in protein and lower in calories. "As adoption grows, we know that consumers' behavior changes," Kempczinski stated, adding that these individuals tend to reduce snacking and opt for less sugary beverages. The company aims to align its offerings with these evolving habits to maintain customer loyalty.
Existing Protein Options and Future Plans
McDonald's already features several protein-heavy items on its menu, including Snack Wraps, Sausage Biscuit sandwiches, and McCrispy Strips. Vice President Jill McDonald confirmed that the chain has long-term goals to serve this demographic, though specific details about upcoming products remain undisclosed. The Independent has reached out to McDonald's for further information on these initiatives.
Industry-Wide Adaptation to GLP-1 Trends
The surge in GLP-1 drug usage in the U.S. has prompted numerous fast-food and restaurant chains to redesign their menus. Smoothie King, for instance, launched a dedicated GLP-1 menu in 2024, featuring smoothies with added protein and fiber and no added sugar. Other major players have followed suit:
- Olive Garden introduced a "lighter portion" section in December, offering smaller, more affordable entrees.
- Chipotle added a protein cup with grilled chicken, providing 32 grams of protein.
- Subway rolled out "Protein Pockets," snack wraps containing over 20 grams of protein.
- Shake Shack created a "Good Fit Menu" with lettuce wraps replacing traditional buns.
Rising Popularity of Weight-Loss Drugs
Originally developed for diabetes treatment, GLP-1 medications have gained popularity as effective weight-loss tools by suppressing appetite and slowing digestion. A November poll from the Kaiser Family Foundation revealed that 12 percent of Americans now report taking a GLP-1 drug, doubling the figure from May of the previous year. This trend underscores the significant impact on consumer behavior and the food industry's rapid response to cater to health-conscious patrons.
